Compass Point initiated coverage on shares of Lineage (NASDAQ:LINE – Free Report) in a report issued on Wednesday, Marketbeat reports. The firm issued a buy rating and a $47.00 price target on the stock. Other analysts have also issued reports about the company. The Goldman Sachs Group decreased their price objective on Lineage from $50.00 […]

Truist Financial began coverage on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report released on Wednesday, Marketbeat reports. The brokerage issued a buy rating and a $12.00 price target on the stock. Other analysts also recently issued reports about the stock. Wall Street Zen downgraded shares of Altimmune from a “hold” rating […]